Literature DB >> 11933209

A review of the phenotypic variation due to the Denys-Drash syndrome-associated germline WT1 mutation R362X.

Rosemary W Heathcott1, Ian M Morison, Marie Claire Gubler, Robin Corbett, Anthony E Reeve.   

Abstract

The gene WT1 is required for the normal development and function of the urogenital tract. Constitutional mutations are associated with familial Wilms tumor and syndromes such as Denys-Drash syndrome (DDS) characterized by nephropathy, genital anomalies and often a predisposition to Wilms tumor. We report a case of constitutional WT1 mutation in an XX female with multifocal Wilms tumor but no genital anomalies or renal dysfunction and, for the first time, review patients previously reported with this germline mutation. The mutation (1084C>T) changes the amino acid arginine at position 362 to the translation stop codon TGA (R362X) resulting in a predicted truncated protein lacking three of the four zinc finger domains necessary for correct functioning of the gene. This constitutional mutation has been reported to cause a variety of phenotypes in eleven different patients, including the classical Denys-Drash phenotype of diffuse mesangial sclerosis which leads to early renal failure, genital anomalies in XY individuals and Wilms tumors. The absence of mesangial sclerosis and renal failure in our patient excludes DDS. Our case differs from those previously described as the normal kidney tissue shows some small subcapsular glomeruli indicating that the WT1 mutation has impaired nephron development. This patient extends the range and variation of phenotypes that may arise from a specific germline mutation in WT1. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11933209     DOI: 10.1002/humu.9031

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  13 in total

Review 1.  Candidate genes and potential targets for therapeutics in Wilms' tumour.

Authors:  Christopher Blackmore; Max J Coppes; Aru Narendran
Journal:  Clin Transl Oncol       Date:  2010-09       Impact factor: 3.405

2.  Genotype/phenotype correlation in nephrotic syndrome caused by WT1 mutations.

Authors:  Gil Chernin; Virginia Vega-Warner; Dominik S Schoeb; Saskia F Heeringa; Bugsu Ovunc; Pawaree Saisawat; Roxana Cleper; Fatih Ozaltin; Friedhelm Hildebrandt
Journal:  Clin J Am Soc Nephrol       Date:  2010-07-01       Impact factor: 8.237

3.  A novel WT1 heterozygous nonsense mutation (p.K248X) causing a mild and slightly progressive nephropathy in a 46,XY patient with Denys-Drash syndrome.

Authors:  Thatiana Evilen da Silva; Mirian Yumie Nishi; Elaine Maria Frade Costa; Regina Matsunaga Martin; Filomena Marino Carvalho; Berenice Bilharinho Mendonca; Sorahia Domenice
Journal:  Pediatr Nephrol       Date:  2011-05-11       Impact factor: 3.714

4.  Imprinting, expression, and localisation of DLK1 in Wilms tumours.

Authors:  R Fukuzawa; R W Heathcott; I M Morison; A E Reeve
Journal:  J Clin Pathol       Date:  2005-02       Impact factor: 3.411

5.  A familial WT1 mutation associated with incomplete Denys-Drash syndrome.

Authors:  Chunhua Zhu; Fei Zhao; Weizhen Zhang; Hongmei Wu; Ying Chen; Guixia Ding; Aihua Zhang; Songming Huang
Journal:  Eur J Pediatr       Date:  2013-05-29       Impact factor: 3.183

6.  A novel WT1 mutation in a 46,XY boy with congenital bilateral cryptorchidism, nystagmus and Wilms tumor.

Authors:  Monica Terenziani; Michele Sardella; Beatrice Gamba; Maria Adele Testi; Filippo Spreafico; Gianluigi Ardissino; Fausto Fedeli; Franca Fossati-Bellani; Paolo Radice; Daniela Perotti
Journal:  Pediatr Nephrol       Date:  2008-12-02       Impact factor: 3.714

7.  Case report: Denys- Drash syndrome.

Authors:  A B Ammari; D E Fung
Journal:  Eur Arch Paediatr Dent       Date:  2007-12

8.  Slow progressive FSGS associated with an F392L WT1 mutation.

Authors:  Petras Kaltenis; Valérie Schumacher; Augustina Jankauskiene; Arvydas Laurinavicius; Brigitte Royer-Pokora
Journal:  Pediatr Nephrol       Date:  2004-01-27       Impact factor: 3.714

Review 9.  The role of WT1 in oncogenesis: tumor suppressor or oncogene?

Authors:  David M Loeb; Saraswati Sukumar
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

10.  Evolutive study of children with diffuse mesangial sclerosis.

Authors:  Ana Pilar Nso Roca; Antonia Peña Carrión; Marta Benito Gutiérrez; Carmen García Meseguer; Araceli García Pose; Mercedes Navarro
Journal:  Pediatr Nephrol       Date:  2008-12-10       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.